Understand the source comparison
P21 Dosage Protocol Guide: Administration Comparison
Standard escalation 5–15mg titrated over 28 days Morning (6–10 AM) 28 days, 14-day washout Cognitive enhancement, learning support Best-supported by neurogenesis timelines; aligns dose with hippocampal cell maturation phases Flat-dose protocol 10mg daily 28–56
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Standard escalation
- 5–15mg titrated over 28 days
- Morning (6–10 AM)
- 28 days, 14-day washout
- Cognitive enhancement, learning support
- Best-supported by neurogenesis timelines; aligns dose with hippocampal cell maturation phases
- Flat-dose protocol
- 10mg daily
- 28–56 days continuous
- Neuroprotection, sustained cognitive support
- Simpler dosing, avoids titration complexity; effective for maintenance rather than acute neurogenic push
- Evening consolidation
- Evening (8–10 PM)
- 28 days
- Memory consolidation, sleep-dependent learning
- Shifts BDNF peak to sleep window; may enhance overnight memory encoding but less daytime plasticity
- High-dose pulsed
- 20–30mg every 3 days
- Variable
- 21–28 days
- Not recommended
- Mismatches receptor kinetics; risks desensitization without sustained signaling window required for neurogenesis
- Maintenance protocol
- 5mg daily
- Morning
- Ongoing post-cycle
- Long-term neuroprotection
- Used after completing 28-day escalation; maintains baseline TrkB activation without further dose escalation
- The standard escalation protocol offers the most precise alignment with hippocampal neurogenesis biology. Titrating dose as progenitor cells proliferate, differentiate, and integrate. Flat-dose protocols sacrifice some theoretical optimization for practical simplicity and still demonstrate meaningful cognitive effects in preclinical models. High-dose pulsed regimens are inconsistent with P21's pharmacokinetics and should be avoided.